ESSERT GmbH was founded in 2012 by Christopher Essert and operates from Bruchsal, Baden-Wuerttemberg, Germany, specialising in modular robotic automation for high-mix, low-volume manufacturing. Indian operations run through distributor networks. The core product is the ESSERT MicroFactory, a scalable platform aimed at pharmaceutical, MedTech, and general industrial applications. ISO 9001:2015 certification underpins the work. Customers include Roche and BASF across more than 10 countries, with the focus on flexible automation for syringes, auto-injectors, and precision medicine. SHS Capital took a majority stake in 2023, and ESSERT opened a U.S. subsidiary, ESSERT Robotics Pharma Corp., in New York in 2022. Awards include the 2018 German Innovation Award and the FANUC Innovation Award for the MicroFactory.